JMS Co Ltd operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JMS Co Ltd with three other
companies in this sector in Japan:
Kawasumi Laboratories, Incorporated
sales of 25.44 billion Japanese Yen [US$226.64 million]
of which 54%
was Extracorporeal Circulation-Related),
(20.10 billion Japanese Yen [US$179.12 million]
Asahi Intecc Co., Ltd.
(50.12 billion Japanese Yen [US$446.61 million]
of which 83%
JMS Co Ltd reported sales of ¥56.52 billion (US$503.59 million)
March of 2018.
a very small
increase of 1.7%
versus 2017, when the company's sales were ¥55.57 billion.
Despite this increase, sales are still
below the level achieved in 2016, when JMS Co Ltd
reported sales of ¥57.64 billion.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
382.3% in 2018, from
¥1.61 billion to ¥7.77 billion.
Not all segments of JMS Co Ltd experienced an increase in sales in 2018:
sales of Operating Segment-China fell 11.6% to ¥1.43 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
JMS Co Ltd also experienced decreases in sales in
Operating Segment-Japan (down 0.1% to ¥37.96 billion)